Fierce Health Technology March 11, 2020
Blue Shield of California will cover rapid whole genome sequencing for children with unexplained medication conditions, becoming the first health plan in the country to do so.
Rady Children’s Institute for Genomic Medicine researchers have developed a method of genome sequencing that takes less than three days, getting the results more quickly into the hands of doctors treating children who are critically ill.
Terry Gilliland, M.D., executive vice president of healthcare quality and affordability at Blue Shield, told FierceHealthcare there are a number of access barriers patients and their families can face if they need such testing, including cost and a potentially lengthy wait for prior authorization processing.
“We really go out in front of this one,”...